Nouvelle déclaration d'incident
No de la demande: 2012-5077
Numéro de référence du titulaire d'homologation: 120075929
Nom du titulaire (nom légal complet, aucune abbréviation): Wellmark International
Adresse: 100 Stone Road West, Suite 111
Ville: Guelph
État: Ontario
Pays: Canada
Code postal /Zip: N1G5L3
Incident chez un animal domestique
Pays: UNITED STATES
État: CALIFORNIA
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 2724-485-270
Nom du produit: Bio Spot Shampoo For Cats And Kittens
Liquide
Oui
Inconnu
Site: Animal / Usage sur un animal domestique
Non
Propriétaire de l'animal
Cat / Chat
Domestic Longhair
1
Homme
0.15
1.06
lbs
Cutanée
>3 days <=1 wk / >3 jours <=1 sem
>8 hrs <=24 hrs / > 8 h < = 24 h
Système
Persisted until death
Oui
Oui
Inconnu
Mort
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
On June 3, 2012 the owner noticed that the kitten was subdued and inappetent. On June 4, 2012 the owner noticed that the kitten was moderately lethargic and severely inappetent. Later that day, the owner took the kitten to the veterinarian, where nutritional support was given with an A D slurry and the kitten was bathed. While at the clinic, the kitten was observed to have hypothermia with a low recorded temperature of 97.0 degrees Fahrenheit, hypoglycemia with a low but unmeasurable serum glucose level, bradycardia with a low recorded heart rate of 100 beats per minute, lateral recumbency, hyphema, and uveitis. That evening, the kitten was no longer lethargic, inappetent, hypothermic, hypoglycemic, bradycardic, or laterally recumbent. On June 5, 2012 the kitten s symptoms worsened, as the kitten developed diarrhea. The veterinarian gave the kitten metronidazole for the diarrhea. The veterinarian also gave the kitten lactated Ringer s solution with dextrose 5 percent and dextrose via bolus. Later that evening, the kitten became mildly lethargic. A couple of hours later, the kitten was discharged from the hospital. However, the kitten s condition worsened and the owner took the kitten to an emergency veterinarian later that evening. Once there, a diagnostic evaluation was performed and the kitten was given symptomatic care. The kitten was severely lethargic, anemic, had elevated serum alanine aminotransferase with a recorded value of 385.0 units per liter (U L), had hypoalbuminema with serum albumin measured at 2.0 grams per deciliter (g dL), had low blood hematocrit measured at 14.0 percent volume to volume (v v) on a spun hematocrit tube and 10.0 percent v v on a veterinary chemistry analyzer, had total solids measured at 7.0 percent v v (normal), had hypophosphatemia with serum alkaline phosphatase measured at 53.0 U L (normal), had elevated gamma glytamyl transpeptidase with serum gamma glutyltranspeptidase measured at 171.0 U L, had hyperkalemia with serum potassium recorded as high, had serum phosphorus measured at 4.1 milligrams per deciliter (mg dL), had hyponatremia with serum sodium measured at 130.0 milliequivalents per liter (mEq L), and had hypoglycemia with serum glucose recorded as low. Early on the morning of June 6, 2012 the kitten died. Later that day, the owner's regular veterinarian contacted the Animal Product Safety Service (APSS) to obtain help. The APSS veterinarian stated that the risk was for mild dermal irritation in sensitive animals and that kittens could be more susceptible to having paresthesia like reaction as well; death, however, would not be expected. The APSS veterinarian recommended a necropsy, but it was declined by the owner.
Mort
The APSS veterinarian stated that the substance was considered to have a doubtful likelihood of causing the clinical situation. A follow up was not performed, because additional information was not expected.